Blog

Comprehensive molecular profiling in lung cancer

AI Generated

Jan 21, 2025, 07:03

Comprehensive molecular profiling in lung cancer

Akhil Santhosh, Medical Oncologist at AIIMS Delhi, shared an article by Joshue E. Reuss et al. on X:

“Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking – Lung Cancer.

Should look out for MET and EGFR alterations.”

Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking

Authors: Joshua E. Reuss, Jacob Zaemes, Nishant Gandhi, Phillip Walker, Sandip P. Patel, Joanne Xiu, Charu Aggarwal, Ari Vanderwalde, Suresh S. Ramalingam, Balazs Halmos, Stephen V. Liu.

Comprehensive molecular profiling in lung cancer

cancer Dr. Akhil Santhosh EGFR alterations genomic alterations Lung cancer Lung Cancer Journal lung cancer research MET alterations molecular profiling non-smokers OncoDaily Oncology smoking history squamous non-small cell lung cancer targeted therapy

FDA approved sotorasib with panitumumab for KRAS G12C-mutated colorectal cancer

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

Karen Knudsen: Clinical trials are the most advanced form of cancer care

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results